CAMP Continuation Study/Phase 2 (CAMPCS/2)

此应用程序是ASTHMA，Inc.研究中心参加儿童哮喘 管理项目延续研究/2期（CAMPCS/2）。 我们成功地继续遵循CAMPCS协议，收集高质量的数据，同时提供安全有效的患者护理。西雅图招募了144名患者参加CAMP，其中127名患者参加了CAMPCS。此外，两名试点患者继续在CAMPCS。在CAMP中完成过渡的患者中，98%继续在CAMPCS中。西雅图CAMPCS研究者和工作人员将继续支持通过CAMPCS/2继续对CAMP患者进行随访。CAMPCS的家属和患者继续致力于这项研究，我们预计他们将继续参与CAMPCS/2。 CAMPCS/2的摘要和研究计划包含在华盛顿的申请中 大学（罗伯特斯特伦克，PI）。

This application is for ASTHMA, Inc. Research Center to participate in the Childhood Asthma Management Program Continuation Study/Phase 2 (CAMPCS/2). We have succeeded in continuing to follow the CAMPCS protocol by collecting data of high quality, while providing safe and efficient patient care. Seattle enrolled 144 patients in CAMP and 127 of these patients have enrolled in CAMPCS. In addition, two pilot patients continue in CAMPCS. Of the patients who completed transition in CAMP, 98% continued on in CAMPCS..Seattle CAMPCS investigators and staff will continue to support the continuation of follow up of CAMP patients through CAMPCS/2. The families and patients of CAMPCS continue to be committed to the study and we anticipate their continued involvement through CAMPCS/2. The abstract and research plan for CAMPCS/2 is included in the application from the Washington University (Robert Strunk, PI).